Mindfulness in Motion Targeted to Sustaining the Mental and Physical Resilience of First Responders

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1This trial used the Mindfulness in Motion program with first responders specifically — since it's already completed, would my doctor know whether the results showed any meaningful changes in stress or resilience scores on the PSS-10 or CD-RISC-10, and how that might apply to my situation?
2. 2Since this was a non-drug, mindfulness-based intervention rather than a medical treatment, how does my doctor weigh it against other established options for managing occupational stress and musculoskeletal discomfort in first responders?
3. 3The trial measured work engagement using the UWES-9 scale — is that an outcome my doctor thinks is clinically meaningful for me personally, or are there other markers of recovery and wellbeing I should focus on?
4. 4Because this trial is completed and was Phase NA — meaning it wasn't a traditional drug trial — how confident is my doctor that we can find and review the published results, and what would those results mean for whether a program like this is worth pursuing?
5. 5Given that this study targeted first responders as a specific group, would my doctor think a mindfulness-in-motion approach is appropriate for my particular role and physical demands, or is there a more tailored program they'd recommend first?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.